Preferences help
enabled [disable] Abstract
Number of results
2015 | 62 | 2 | 297-302
Article title

Association of the DIO2 gene single nucleotide polymorphisms with recurrent depressive disorder

Title variants
Languages of publication
Genetic factors may play a role in the etiology of depressive disorder. The type 2 iodothyronine deiodinase gene (DIO2) encoding the enzyme catalyzing the conversion of T4 to T3 is suggested to play a role in the recurrent depressive disorder (rDD). The current study investigates whether a specific single nucleotide polymorphism (SNP) of the DIO2 gene, Thr92Ala (T/C); rs 225014 or ORFa-Gly3Asp (C/T); rs 12885300, correlate with the risk for recurrent depression. Genotypes for these two single nucleotide polymorphisms (SNPs) were determined in 179 patients meeting the ICD-10 criteria for rDD group and in 152 healthy individuals (control group) using a polymerase chain reaction (PCR) based method. The specific variant of the DIO2 gene, namely the CC genotype of the Thr92Ala polymorphism, was more frequently found in healthy subjects than in patients with depression, what suggests that it could potentially serve as a marker of a lower risk for recurrent depressive disorder. The distribution of four haplotypes was also significantly different between the two study groups with the TC (Thr-Gly) haplotype more frequently detected in patients with depression. In conclusion, data generated from this study suggest for the first time that DIO2 gene may play a role in the etiology of the disease, and thus should be further investigated.
Physical description
  • Department of Pneumology and Allergy, Medical University of Łódź, Łódź, Poland
  • Department of Adult Psychiatry, Medical University of Łódź, Łódź, Poland
  • Department of Adult Psychiatry, Medical University of Łódź, Łódź, Poland
  • Department of Pneumology and Allergy, Medical University of Łódź, Łódź, Poland
  • Department of Quality Control and Radiological Protection, Medical University of Łódź, Łódź, Poland
  • Department of Medical Biochemistry, Medical University of Łódź, Łódź, Poland
  • Almandoz JP, Gharib H (2012) Hypothyroidism: etiology, diagnosis, and management. Med Clin North Am 96: 203-221.
  • Anisman H (2011) Inflaming depression. J Psychiatry Neurosci 36: 291-295.
  • Babenko A, Popkova D, Freylihman O, Solncev V, Kostareva A, Grineva E (2012) Thr92Ala polymorphism of human type 2 deiodinase gene (hD2) affects the development of Graves' disease, treatment efficiency, and rate of remission. Clin Dev Immunol ID340542.
  • Bauer M, Goetz T, Glenn T, Whybrow PC (2008) The thyroid-brain interaction in thyroid disorders and mood disorders. J Neuroendocrinol 20: 1101-1104.
  • Bauer M, Heinz A, Whybrow PC (2002) Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain. Mol Psychiatry 7: 140-156.
  • Baumgartner A, Dubeyko M, Campos-Barros A, Eravci M, Meinhold H (1994) Subchronic administration of fluoxetine to rats affects triiodothyronine production and deiodination in regions of the cortex and in the limbic forebrain. Brain Res 635: 68-74.
  • Baumgartner A, Gräf KJ, Kürten I, Meinhold H (1998) The hypothalamic-pituitary-thyroid axis in psychiatric patients and healthy subjects: Parts 1-4. Psychiatry Res 24: 271-332.
  • Belmaker RH, Agam G (2008) Major depressive disorder. N Engl J Med 358: 55-68.
  • Bianco AC, Kim BW (2006) Deiodinases: implications of the local control of thyroid hormone action. J Clin Invest 116: 2571-2579.
  • Boelen A, Kwakkel J, Fliers E (2011) Beyond low plasma T3: local thyroid hormone metabolism during inflammation and infection. Endocr Rev 32: 670-693.
  • Bonnin CM, Martinez-Aran A, Sanchez-Moreno J, Torrent C, Franco C, Pacchiarotti I, Viet E (2010) Bipolar disorder, cognitive functioning and hypothalamic-pituitary-thyroid axis. Actas Esp Psiquiatr 38: 223-228.
  • Bos SD, Bovée JV, Duijnisveld BJ, Raine EV, van Dalen WJ, Ramos YF, van der Breggen R, Nelissen RG, Slagboom PE, Loughlin J, Meulenbelt I (2012) Increased type II deiodinase protein in OA-affected cartilage and allelic imbalance of OA risk polymorphism rs225014 at DIO2 in human OA joint tissues. Ann Rheum Dis 71: 1254-1258.
  • Bunevicius R, Prange AJ JR (2010) Thyroid disease and mental disorders: cause and effect or only comorbidity? Curr Opin Psychiatry 23: 363-368.
  • Butler PW, Smith SM, Linderman JD, Brychta RJ, Alberobello AT, Dubaz OM, Luzon JA, Skarulis MC, Cochran CS, Wesley RA, Pucino F, Celi FS (2010) The Thr92Ala 5' type 2 deiodinase gene polymorphism is associated with a delayed triiodothyronine secretion in response to the thyrotropin-releasing hormone-stimulation test: a pharmacogenomic study. Thyroid 20: 1407-1412.
  • Canani LH, Capp C, Dora JM, Meyer EL, Wagner MS, Harney JW, Larsen PR, Gross JL, Bianco AC, Maia AL (2005) The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 90: 3472-3478.
  • Cooper DS (2001) Clinical practice. Subclinical hypothyroidism. N Engl J Med 345: 260-265.
  • Cooper-Kazaz R, van der Deure WM, Medici M, Visser TJ, Alkelai A, Glaser B, Peeters RP, Lerer B (2009) Preliminary evidence that a functional polymorphism in type 1 deiodinase is associated with enhanced potentiation of the antidepressant effect of sertraline by triiodothyronine. J Affect Disord 116: 113-116.
  • de Jong FJ, Peeters RP, den Heijer T, van der Deure WM, Hofman A, Uitterlinden AG, Visser TJ, Breteler MW (2007) The association of polymorphisms in the type 1 and 2 deiodinase genes with circulating thyroid hormone parameters and atrophy of the medial temporal lobe. J Clin Endocrinol Metab 92: 636-640.
  • Dentice M, Bandyopadhyay A, Gereben B, Callebaut I, Christoffolete MA, Kim BW, Nissim S, Mornon JP, Zavacki AM, Zeöld A, Capelo LP, Curcio-Morelli C, Ribeiro R, Harney JW, Tabin CJ, Bianco AC (2005) The Hedgehog-inducible ubiquitin ligase subunit WSB-1 modulates thyroid hormone activation and PTHrP secretion in the developing growth plate. Nat Cell Biol 7: 698-705.
  • Dora JM, Machado WE, Rheinheimer J, Crispim D, Maia AL (2010) Association of the type 2 deiodinase Thr92Ala polymorphism with type 2 diabetes: case-control study and meta-analysis. Eur J Endocrinol 163: 427-434.
  • Eravci M, Pinna G, Meinhold H, Baumgartner A (2000) Effects of pharmacological and nonpharmacological treatments on thyroid hormone metabolism and concentrations in rat brain. Endocrinology 141: 1027-1040.
  • Fountoulakis KN, Kantartzis S, Siamouli M, Panagiotidis P, Kaprinis S, Iacovides A, Kaprinis G (2006) Peripheral thyroid dysfunction in depression. World J Biol Psychiatry 7: 131-137.
  • Galton VA, Wood ET, Germain EA St, Withrow CA, Aldrich G, Germain GM St, Clark AS, Germain DL St (2007) Thyroid hormone homeostasis and action in the type 2 deiodinase-deficient rodent brain during development. Endocrinology 148: 3080-3088.
  • Guerra A, Sapio MR, Carrano M, Di Stasi V, Volpe A, Murino A, Izzo G, Vitale M (2013) Prevalence of Dio2T92A polymorphism and its association with thyroid autoimmunity J Endocrinol Invest 36: 303-306.
  • Guo TW, Zhang FC, Yang MS, Gao XC, Bian L, Duan SW, Zheng ZJ, Gao JJ, Wang H, Li RL, Feng GY, Clair D St, He L (2004) Positive association of the DIO2 (deiodinase type 2) gene with mental retardation in the iodine-deficient areas of China. J Med Genet 41: 585-590.
  • He B, Li J, Wang G, Ju W, Lu Y, Shi Y, He L, Zhong N (2009) Association of genetic polymorphisms in the type II deiodinase gene with bipolar disorder in a subset of Chinese population. Prog Neuropsychopharmacol Biol Psychiatry 33: 986-990.
  • Hoftijzer HC, Heemstra KA, Visser TJ, le Cessie S, Peeters RP, Corssmit EP, Smit JW (2011) The type 2 deiodinase ORFa-Gly3Asp polymorphism (rs12885300) influences the set point of the hypothalamus-pituitary-thyroid axis in patients treated for differentiated thyroid carcinoma. J Clin Endocrinol Metab 96: E1527-E1533.
  • ICD-10 Classification of Mental and Behavioural Disorders. (1992) WHO: Geneva.
  • Joffe RT (2011) Hormone treatment of depression. Dialogues Clin Neurosci 13: 127-138.
  • Kirkegaard C, Faber J (1991) Free thyroxine and 3,3',5'-triiodothyronine levels in cerebrospinal fluid in patients with endogenous depression. Acta Endocrinol. (Copenh) 124: 166-172.
  • Köhrle J (1999) Local activation and inactivation of thyroid hormones: the deiodinase family. Mol Cell Endocrinol 151: 103-119.
  • Ma SF, Xie L, Pino-Yanes M, Sammani S, Wade MS, Letsiou E, Siegler J, Wang T, Infusino G, Kittles RA, Flores C, Zhou T, Prabhakar BS, Moreno-Vinasco L, Villar J, Jacobson SM, Dudek JG, Garcia JG (2011) Am J Respir Cell Mol Biol 45: 1203-1211.
  • Maes M, Leunis JC (2008) Normalization of leaky gut in chronic fatigue syndrome (CFS) is accompanied by a clinical improvement: effects of age, duration of illness and the translocation of LPS from gram-negative bacteria. Neuro Endocrinol Lett 29: 902-910.
  • Maes M, Leonard B, Fernandez A, Kubera M, Nowak G, Veerhuis R, Gardner A, Ruckoanich P, Geffard M, Altamura C, Galecki P, Berk M (2011) (Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: from antioxidants to kinase inhibitors. Prog Neuropsychopharmacol Biol Psychiatry 35: 659-663.
  • Murray EA, Wise SP, Drevets WC (2011) Localization of dysfunction in major depressive disorder: prefrontal cortex and amygdale. Biol Psychiatry 69: e43-e54.
  • Nair S, Muller YL, Ortega E, Kobes S, Bogardus C, Baier LJ (2012) Association analyses of variants in the DIO2 gene with early-onset type 2 diabetes mellitus in Pima Indians. Thyroid 22: 80-87.
  • Panicker V, Saravanan P, Vaidya B, Evans J, Hattersley AT, Frayling TM, Dayan CM (2009) Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients. J Clin Endocrinol Metab 94: 1623-1629.
  • Patten S (1999) Performance of the composite international diagnostic interview short form for major depression in community and clinical samples. Chronic Dis Can 3: 18-24.
  • Peeters RP, van den Beld AW, Attalki H, Toor H, de Rijke YB, Kuiper GG, Lamberts SW, Janssen JA, Uitterlinden AG, Visser TJ (2005) A new polymorphism in the type II deiodinase gene is associated with circulating thyroid hormone parameters. Am J Physiol Endocrinol Metab 289: E75-E81.
  • Peltsverger MY, Butler PW, Alberobello AT, Smith S, Guevara Y, Dubaz OM, Luzon JA, Linderman J, Celi FS (2012) The -258A/G (SNP rs12885300) polymorphism of the human type 2 deiodinase gene is associated with a shift in the pattern of secretion of thyroid hormones following a TRH-induced acute rise in TSH. Eur J Endocrinol 166: 839-845.
  • Pinna G, Broedel O, Eravci M, Stoltenburg-Didinger G, Plueckhan H, Fuxius S, Meinhold H, Baumgartner A (2003) Thyroid hormones in the rat amygdala as common targets for antidepressant drugs, mood stabilizers, and sleep deprivation. Biol Psychiatry 54: 1049-1059.
  • Premachandra BN, Kabir MA, Williams IK (2006) Low T3 syndrome in psychiatric depression. J Endocrinol Invest 29: 568-572.
  • Rao ML, Ruhrmann S, Retey B, Liappis N, Fuger J, Kraemer M, Kasper S, Möller HJ (1996) Low plasma thyroid indices of depressed patients are attenuated by antidepressant drugs and influence treatment outcome. Pharmacopsychiatry 29: 180-186.
  • Samuels MH (2008) Cognitive function in untreated hypothyroidism and hyperthyroidism. Curr Opin Endocrinol Diabetes Obes 15: 429-433.
  • Stipcević T, Pivac N, Kozarić-Kovacić D, Mück-Seler D (2008) Thyroid activity in patients with major depression. Coll Antropol 32: 973-976.
  • Toft AD (2001) Clinical practice. Subclinical hyperthyroidism. N Engl J Med 345: 512-566.
  • Torlontano M, Durante C, Torrente I, Crocetti U, Augello G, Ronga G, Montesano T, Travascio L, Verrienti A, Bruno R, Santini S, D'Arcangelo P, Dallapiccola B, Filetti S, Trischitta V (2008) Type 2 deiodinase polymorphism (threonine 92 alanine) predicts L-thyroxine dose to achieve target thyrotropin levels in thyroidectomized patients. Clin Endocrinol Metab 93: 910-913.
  • Taylor JW (1975) Depression in thyrotoxicosis. Am J Psychiatry 132: 552-553.
  • Whiteford HA, Degenhardt L, Rehm J, Baxte AJ, Ferrari AJ, Erskine HE, Charlson FJ, Norman RE, Flaxman AD, Johns N, Burstein R, Murray CJ, Vos T (2013) Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 382: 1575-1586.
  • Williams GR (2008) Neurodevelopmental and neurophysiological actions of thyroid hormone. J Neuroendocrinol 20: 784-794.
  • Zevenbergen C1, Klootwijk W, Peeters RP, Medici M, de Rijke YB, Huisman SA, Goeman H, Boot E, de Kuijper G, de Waal KH, Meima ME, Larsen PR, Visser TJ, Visser WE (2014) Functional analysis of novel genetic variation in the thyroid hormone activating type 2 deiodinase. J Clin Endocrinol Metab 99: E2429-E2436.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.